Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Sea Limited (SE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Sea Limited — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.47B), while Sea Limited trades at $94.6 (market cap $58.38B). The key difference: Sea Limited is far larger — about 6.9× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Sea Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Sea Limited for 103 Days on average.
| HNGE | SE | |
|---|---|---|
Market Cap | $8.47B | $58.38B |
Volume | 1,624,526 | 3,918,232 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.14 | $165.70 |
52-Week Low | $31.17 | $78.16 |
Typical Hold Time | 0 Days | 103 Days |
Enterprise Value | $8.09B | $53.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Sea Limited (SE) trades at $95.93, showing minimal daily movement with a 0.05% gain. The stock faces bearish technical signals but maintains strong fundamental growth with revenue increasing from $12.4B in 2022 to $22.9B in 2025. Recent earnings show mixed results with Q4 2025 missing expectations but Q1 and Q2 2026 beating estimates. Analyst sentiment remains overwhelmingly positive with 72.7% buy ratings and a $153.67 consensus price target representing 60% upside potential.
Sea's investment case hinges on continued e-commerce and fintech expansion, though recent insider selling and competitive pressures pose risks. The company's improving profitability trajectory and strong cash flow generation support long-term growth prospects, but investors should monitor execution on Shopee's margin improvement and Garena's gaming segment stability amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Sea Limited
Sea Limited offers information technology services. The Company provides online personal computer and mobile digital content, e-commerce, and payment platforms. Sea serves customers worldwide.
Read more on SE →
